There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
All content for Making Medicine is the property of Incubate Coalition and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
Ned Sharpless on Biotech’s Future, HHS Shifts, and Global Competition | Making Medicine Podcast
Making Medicine
52 minutes
4 months ago
Ned Sharpless on Biotech’s Future, HHS Shifts, and Global Competition | Making Medicine Podcast
This week, John Stanford sits down with Dr. Ned Sharpless - former NCI Director, Acting FDA Commissioner, and now venture capitalist at Jupiter Bio Ventures. From the challenges of biotech funding, regulatory uncertainty, and the Inflation Reduction Act to the rise of China in biotech, IP battles, and the hype around AI, Ned offers candid insights you won’t hear anywhere else.
What do you think about the current funding environment in biotech? How should the U.S. respond to China’s scientific rise?
📱If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more: https://x.com/MakingMedPod https://www.instagram.com/makingmedicinepod/ https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=true
Timestamps: 0:00 Welcome to Making Medicine 0:12 Guest introduction: Dr. Ned Sharpless 1:03 Launch of Jupiter Bio Ventures 3:31 The tough biotech funding environment 5:27 Regulatory uncertainty, IRA, and FDA challenges 8:02 Leadership turmoil at FDA, NIH, and HHS 10:18 RFK Jr.’s vision and impact on health policy 13:05 Morale, recruitment, and expertise at federal agencies 15:20 How NIH, FDA, and CMS work together 19:00 NIH funding freezes and Congressional outlook 23:36 FDA’s new priority review voucher program 28:02 Public skepticism, politics, and FDA trust 30:02 The “pill penalty,” EPIC Act, and IRA fixes 34:04 Why small molecules still matter for cancer 35:40 IP protections, march-in rights, and investment risks 39:20 The debate over Most Favored Nation drug pricing 43:12 Direct-to-consumer pricing as a potential solution 44:38 AI in biotech-hype vs. reality 46:46 China’s rise in biotech and global competition 50:11 Closing thoughts and optimism for science
Making Medicine
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
